Table 2. The research results of all included studies in the meta-analysis.
Author(year) | PTN expression | Tumor size | LNM | DM | HG | TNM stage | OS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
big | small | yes | no | yes | no | H/M | L | Ⅰ/Ⅱ | Ⅲ/Ⅳ | HR | 95%CI | In(HR) | Se((InHR)) | ||
Hye -Sung 2002 | High | - | - | - | - | - | - | - | - | 17 | 7 | - | - | - | - |
Low | - | - | - | - | - | - | - | - | 18 | 0 | - | - | - | - | |
H.Wu2005 | High | - | - | - | - | 14 | 6 | - | - | - | - | 0.698 | 0.02–20.04 | -0.36 | 1.72 |
Low | - | - | - | - | 1 | 13 | - | - | - | - | - | - | - | - | |
Jun Yao2009 | High | 7 | 17 | 18 | 6 | 4 | 20 | 18 | 6 | 8 | 16 | 1.323 | 0.34–5.1 | 0.28 | 0.69 |
Low | 0 | 14 | 5 | 9 | 0 | 14 | 6 | 8 | 12 | 2 | - | - | - | - | |
YingKong2012 | High | 29 | 13 | - | - | - | - | 23 | 27 | 13 | 37 | - | - | - | - |
Low | 16 | 8 | - | - | - | - | 24 | 9 | 16 | 17 | - | - | - | - | |
Jiequn Ma2014 | High | 99 | 27 | - | - | - | - | 34 | 92 | - | - | 2.024 | 1.107–3.695 | 0.705 | 0.307 |
Low | 31 | 11 | - | - | - | - | 21 | 21 | - | - | - | - | - | - | |
Lei Zhang2015 | High | - | - | - | - | - | - | - | - | - | - | 1.878 | 0.8–4.41 | 0.63 | 0.44 |
Low | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Lei Zhang2015 | High | - | - | - | - | - | - | - | - | - | - | 1.768 | 1.2–2.6 | 0.57 | 0.2 |
Low | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
HQ.Wang2015 | High | 27 | 14 | 26 | 15 | 5 | 36 | 24 | 17 | 21 | 20 | - | - | - | - |
Low | 39 | 3 | 30 | 12 | 7 | 35 | 32 | 10 | 30 | 12 | - | - | - | - | |
PeisongBai2017 | High | 31 | 16 | - | - | - | - | - | - | 25 | 22 | 1.682 | 0.96–2.97 | 0.52 | 0.29 |
Low | 21 | 12 | - | - | - | - | - | - | 30 | 3 | - | - | - | - | |
DapengWu2017 | High | - | - | - | - | 21 | 38 | - | - | 25 | 34 | 1.584 | 0.982–2.553 | 0.46 | 0.244 |
Low | - | - | - | - | 17 | 57 | - | - | 41 | 33 | - | - | - | - | |
Jiequn Ma2017 | High | 33 | 14 | 32 | 15 | - | - | 14 | 33 | 27 | 20 | 2.901 | 1–8.1 | 1.065 | 0.534 |
Low | 19 | 14 | 15 | 18 | - | - | 18 | 15 | 23 | 10 | - | - | - | - |
DM, distant metastases; LNM, lymph node metastases; HG, histological grade; OS, Overall survival.